We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Reinforced Cardiac Shunt Helps Repair Serious Heart Defect

By HospiMedica International staff writers
Posted on 07 Jul 2015
A new study shows that using a ring-reinforced shunt improves surgical outcomes in children born with hypoplastic left heart syndrome (HLHS).

Researchers at Boston Children’s Hospital (MA, USA) and Harvard Medical School (Boston, MA, USA) conducted a retrospective review of 87 patients with HLHS who underwent Norwood Stage-1 surgery. More...
Of these, 48 patients received the standard, non-reinforced Gore-Tex right-ventricle-to-pulmonary-artery (RV-PA) conduit, and 39 received the same conduit, but reinforced with rings. The -reinforced graft was placed through a limited ventriculotomy. Primary and secondary outcomes were survival and need for cardiac re-intervention up to age 12 months.

The results showed that a ring-reinforced conduit was associated with reduced intervention, as well as higher pulse pressures and improved pulmonary artery (PA) growth. There was no difference in transplant-free survival by age 12 months, but those with the non-reinforced grafts had more interventions during their first year (69% versus 35%, respectively). Survival to discharge after the first stage Norwood surgery was 98% in the ring-reinforced group, compared with 83% in the non-reinforced group. In addition, survival at 12 months was higher in the ring-reinforced group (92% versus 75%). The study was published in the June 2015 issue of the Journal of Thoracic and Cardiovascular Surgery.

“The technique of using a ring-reinforced graft in conjunction with a limited right ventricular incision has theoretic advantages in preserving right ventricular function,” said lead author Audrey Marshall, MD, of the department of cardiology. “The ring-reinforced conduit maintains a uniform interior passageway for blood flow.”

“Although avoiding the use of a non-reinforced conduit may seem to be a minor adjustment in technique, the potential for important long-term patient benefit cannot be disregarded,” said Charles Fraser Jr., MD, of Texas Children's Hospital (Houston, USA) in an editorial commentary. “While the journey toward staged HLHS palliation was begun several decades ago and there have been many steps, it remains an arduous journey. Even a small step of progress encourages further focus.”

HLHS is a congenital defect in which the left side of the heart does not develop properly, impairing normal circulation. Children with this condition undergo a series of three reconstructive surgeries, called the Norwood Procedure, to help restore oxygenated blood flow. The first stage attempts to permit the normally functioning right ventricle to pump blood to both the lungs and the body. The second stage, the Bi-directional Glenn Shunt Procedure, follows when the infant is between four and six months old. The third step is the Fontan Procedure, which is carried out between 18 months to three years of age. Since only about 50% of children survive this three-part surgical series after five years, surgeons are always looking for ways to improve outcomes.

Related Links:

Boston Children’s Hospital
Harvard Medical School



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.